419 related articles for article (PubMed ID: 15322702)
1. Extracellular signal regulated kinase and SMAD signaling both mediate the angiotensin II driven progression towards overt heart failure in homozygous TGR(mRen2)27.
de Boer RA; Pokharel S; Flesch M; van Kampen DA; Suurmeijer AJ; Boomsma F; van Gilst WH; van Veldhuisen DJ; Pinto YM
J Mol Med (Berl); 2004 Oct; 82(10):678-87. PubMed ID: 15322702
[TBL] [Abstract][Full Text] [Related]
2. Specific MAP-kinase blockade protects against renal damage in homozygous TGR(mRen2)27 rats.
de Borst MH; Navis G; de Boer RA; Huitema S; Vis LM; van Gilst WH; van Goor H
Lab Invest; 2003 Dec; 83(12):1761-70. PubMed ID: 14691294
[TBL] [Abstract][Full Text] [Related]
3. Imatinib attenuates end-organ damage in hypertensive homozygous TGR(mRen2)27 rats.
Schellings MW; Baumann M; van Leeuwen RE; Duisters RF; Janssen SH; Schroen B; Peutz-Kootstra CJ; Heymans S; Pinto YM
Hypertension; 2006 Mar; 47(3):467-74. PubMed ID: 16432052
[TBL] [Abstract][Full Text] [Related]
4. Early onset of chondroitin sulfate and osteopontin expression in angiotensin II-dependent left ventricular hypertrophy.
Rothermund L; Kreutz R; Kossmehl P; Fredersdorf S; Shakibaei M; Schulze-Tanzil G; Paul M; Grimm D
Am J Hypertens; 2002 Jul; 15(7 Pt 1):644-52. PubMed ID: 12118914
[TBL] [Abstract][Full Text] [Related]
5. Dissociation of angiotensin II-stimulated activation of mitogen-activated protein kinase kinase from vascular contraction.
Watts SW; Florian JA; Monroe KM
J Pharmacol Exp Ther; 1998 Sep; 286(3):1431-8. PubMed ID: 9732408
[TBL] [Abstract][Full Text] [Related]
6. Induction of kidney injury molecule-1 in homozygous Ren2 rats is attenuated by blockade of the renin-angiotensin system or p38 MAP kinase.
de Borst MH; van Timmeren MM; Vaidya VS; de Boer RA; van Dalen MB; Kramer AB; Schuurs TA; Bonventre JV; Navis G; van Goor H
Am J Physiol Renal Physiol; 2007 Jan; 292(1):F313-20. PubMed ID: 16896183
[TBL] [Abstract][Full Text] [Related]
7. Effects of AT1 receptor blockade on renal injury and mitogen-activated protein activity in Dahl salt-sensitive rats.
Nishiyama A; Yoshizumi M; Rahman M; Kobori H; Seth DM; Miyatake A; Zhang GX; Yao L; Hitomi H; Shokoji T; Kiyomoto H; Kimura S; Tamaki T; Kohno M; Abe Y
Kidney Int; 2004 Mar; 65(3):972-81. PubMed ID: 14871417
[TBL] [Abstract][Full Text] [Related]
8. Effects of angiotensin II subtype 1 receptor blockade on cardiac fibrosis and sarcoplasmic reticulum Ca2+ handling in hypertensive transgenic rats overexpressing the Ren2 gene.
Rothermund L; Pinto YM; Vetter R; Herfort N; Kossmehl P; Neumayer HH; Paul M; Kreutz R
J Hypertens; 2001 Aug; 19(8):1465-72. PubMed ID: 11518855
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II-mediated oxidative stress promotes myocardial tissue remodeling in the transgenic (mRen2) 27 Ren2 rat.
Whaley-Connell A; Govindarajan G; Habibi J; Hayden MR; Cooper SA; Wei Y; Ma L; Qazi M; Link D; Karuparthi PR; Stump C; Ferrario C; Sowers JR
Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E355-63. PubMed ID: 17440033
[TBL] [Abstract][Full Text] [Related]
10. Stage-specific differential activation of mitogen-activated protein kinases in hypertrophied and failing rat hearts.
Hayashida W; Kihara Y; Yasaka A; Inagaki K; Iwanaga Y; Sasayama S
J Mol Cell Cardiol; 2001 Apr; 33(4):733-44. PubMed ID: 11273726
[TBL] [Abstract][Full Text] [Related]
11. Edaravone inhibits pressure overload-induced cardiac fibrosis and dysfunction by reducing expression of angiotensin II AT1 receptor.
Zhang WW; Bai F; Wang J; Zheng RH; Yang LW; James EA; Zhao ZQ
Drug Des Devel Ther; 2017; 11():3019-3033. PubMed ID: 29081650
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta receptor endoglin is expressed in cardiac fibroblasts and modulates profibrogenic actions of angiotensin II.
Chen K; Mehta JL; Li D; Joseph L; Joseph J
Circ Res; 2004 Dec; 95(12):1167-73. PubMed ID: 15539634
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II activates collagen I gene through a mechanism involving the MAP/ER kinase pathway.
Tharaux PL; Chatziantoniou C; Fakhouri F; Dussaule JC
Hypertension; 2000 Sep; 36(3):330-6. PubMed ID: 10988260
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II blockade prevents hyperglycemia-induced activation of JAK and STAT proteins in diabetic rat kidney glomeruli.
Banes AK; Shaw S; Jenkins J; Redd H; Amiri F; Pollock DM; Marrero MB
Am J Physiol Renal Physiol; 2004 Apr; 286(4):F653-9. PubMed ID: 14678947
[TBL] [Abstract][Full Text] [Related]
15. Renin-angiotensin system and myocardial collagen matrix: modulation of cardiac fibroblast function by angiotensin II type 1 receptor antagonism.
Brilla CG; Scheer C; Rupp H
J Hypertens Suppl; 1997 Dec; 15(6):S13-9. PubMed ID: 9493122
[TBL] [Abstract][Full Text] [Related]
16. Telmisartan delays myocardial fibrosis in rats with hypertensive left ventricular hypertrophy by TGF-β1/Smad signal pathway.
Zhang Y; Shao L; Ma A; Guan G; Wang J; Wang Y; Tian G
Hypertens Res; 2014 Jan; 37(1):43-9. PubMed ID: 24089264
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin receptor antagonism and angiotensin converting enzyme inhibition improve diastolic dysfunction and Ca(2+)-ATPase expression in the sarcoplasmic reticulum in hypertensive cardiomyopathy.
Flesch M; Schiffer F; Zolk O; Pinto Y; Stasch JP; Knorr A; Ettelbrück S; Böhm M
J Hypertens; 1997 Sep; 15(9):1001-9. PubMed ID: 9321748
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II subtype-1 receptor blockade during the development of left ventricular hypertrophy in dogs: effects on ventricular and myocyte function.
Spinale FG; Holzgrefe HH; Walker JD; Mukherjee R; Kribbs SB; Powell JR; Antonaccio M
J Cardiovasc Pharmacol; 1997 Nov; 30(5):623-31. PubMed ID: 9388045
[TBL] [Abstract][Full Text] [Related]
19. Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitro.
Aoki H; Richmond M; Izumo S; Sadoshima J
Biochem J; 2000 Apr; 347 Pt 1(Pt 1):275-84. PubMed ID: 10727428
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II activates connective tissue growth factor and induces extracellular matrix changes involving Smad/activation and p38 mitogen-activated protein kinase signalling pathways in human dermal fibroblasts.
Zhang GY; Li X; Yi CG; Pan H; He GD; Yu Q; Jiang LF; Xu WH; Li ZJ; Ding J; Lin DS; Gao WY
Exp Dermatol; 2009 Nov; 18(11):947-53. PubMed ID: 19397700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
